• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊索瘤理解与管理的最新进展:最新情况

Recent advances in understanding and managing chordomas: an update.

作者信息

Connors Scott W, Aoun Salah G, Shi Chen, Peinado-Reyes Valery, Hall Kristen, Bagley Carlos A

机构信息

Department of Neurological Surgery, University of Texas Southwestern School of Medicine, Dallas, TX, USA.

UT Southwestern Spine Center, University of Texas Southwestern School of Medicine, Dallas, TX, USA.

出版信息

F1000Res. 2020 Jul 16;9. doi: 10.12688/f1000research.22440.1. eCollection 2020.

DOI:10.12688/f1000research.22440.1
PMID:32724558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7366033/
Abstract

Chordomas are rare and difficult-to-treat tumors arising from the embryonic notochord. While surgery is the mainstay of treatment, and despite new techniques aimed at maximizing total tumoral resection, recurrence remains high and the probability of disease-free survival low. New breakthroughs in genetics, targeted molecular therapy, and heavy-particle beam therapy offer some promise as adjuvant treatments in addition to surgical resection. A multidisciplinary approach encompassing genetics, immunotherapy, radiation therapy, and surgery, at a facility experienced in the management of this complex disease, offers the best chance of survival and quality of life to patients while limiting the intrinsic morbidity of these treatments.

摘要

脊索瘤是一种罕见且难以治疗的肿瘤,起源于胚胎脊索。虽然手术是主要治疗方法,尽管有旨在最大限度地实现肿瘤全切的新技术,但复发率仍然很高,无病生存率很低。遗传学、靶向分子治疗和重粒子束治疗方面的新突破为除手术切除外的辅助治疗带来了一些希望。在一家有处理这种复杂疾病经验的机构,采用涵盖遗传学、免疫治疗、放射治疗和手术的多学科方法,可为患者提供最佳的生存机会和生活质量,同时限制这些治疗的固有发病率。

相似文献

1
Recent advances in understanding and managing chordomas: an update.脊索瘤理解与管理的最新进展:最新情况
F1000Res. 2020 Jul 16;9. doi: 10.12688/f1000research.22440.1. eCollection 2020.
2
The biological basis for modern treatment of chordoma.现代治疗 chordoma 的生物学基础。
J Neurooncol. 2011 Sep;104(2):411-22. doi: 10.1007/s11060-011-0559-8. Epub 2011 Mar 8.
3
[From bench to bedside for new treatment paradigms in chordomas: An update].[从脊索瘤新治疗模式的实验台到临床应用:最新进展]
Bull Cancer. 2020 Jan;107(1):129-135. doi: 10.1016/j.bulcan.2019.10.008. Epub 2019 Dec 24.
4
Contemporary management of clival chordomas.斜坡脊索瘤的现代治疗
Curr Opin Otolaryngol Head Neck Surg. 2015 Apr;23(2):153-61. doi: 10.1097/MOO.0000000000000140.
5
Recent advances in understanding and managing chordomas.脊索瘤的认识与治疗新进展
F1000Res. 2016 Dec 22;5:2902. doi: 10.12688/f1000research.9499.1. eCollection 2016.
6
Systemic therapy options for unresectable and metastatic chordomas.不可切除和转移性脊索瘤的系统治疗选择。
Curr Oncol Rep. 2011 Aug;13(4):323-30. doi: 10.1007/s11912-011-0176-x.
7
[Particle beam radiotherapy with a surgical spacer placement for unresectable sacral chordoma].[不可切除骶骨脊索瘤的粒子束放疗联合手术置入间隔物]
Gan To Kagaku Ryoho. 2010 Nov;37(12):2804-6.
8
Chordoma: the nonsarcoma primary bone tumor.脊索瘤:非肉瘤性原发性骨肿瘤。
Oncologist. 2007 Nov;12(11):1344-50. doi: 10.1634/theoncologist.12-11-1344.
9
[Chordoma].[脊索瘤]
Neurochirurgie. 2014 Jun;60(3):63-140. doi: 10.1016/j.neuchi.2014.02.003. Epub 2014 May 23.
10
Chordoma: Genetics and Contemporary Management.脊索瘤:遗传学与当代管理。
Int J Mol Sci. 2024 May 28;25(11):5877. doi: 10.3390/ijms25115877.

引用本文的文献

1
Rare Extra-Axial Chordoma of the Anteromedial Thigh: A Case Report.大腿前内侧罕见的轴外脊索瘤:病例报告
Clin Case Rep. 2025 Apr 22;13(4):e70341. doi: 10.1002/ccr3.70341. eCollection 2025 Apr.
2
Long-Term Outcomes of Patients Diagnosed With Sacral Chordoma in a Retrospective Multicenter Study.一项回顾性多中心研究中骶骨脊索瘤患者的长期预后
Cancer Control. 2025 Jan-Dec;32:10732748251323730. doi: 10.1177/10732748251323730. Epub 2025 Mar 11.
3
Five-Fraction Proton Therapy for the Treatment of Skull Base Chordomas and Chondrosarcomas: Early Results of a Prospective Series and Description of a Clinical Trial.五分割质子治疗颅底脊索瘤和软骨肉瘤:前瞻性系列研究的早期结果及一项临床试验的描述
Cancers (Basel). 2023 Nov 25;15(23):5579. doi: 10.3390/cancers15235579.
4
Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base Chordoma.剂量递增质子治疗颅底脊索瘤后的临床结果
Int J Part Ther. 2021 Jun 25;8(1):179-188. doi: 10.14338/IJPT-20-00066.1. eCollection 2021 Summer.

本文引用的文献

1
Comparison of Wide Margin and Inadequate Margin for Recurrence in Sacral Chordoma: A Meta-Analysis.广泛切缘与不足切缘对骶骨脊索瘤复发影响的比较:一项荟萃分析。
Spine (Phila Pa 1976). 2020 Jun 15;45(12):814-819. doi: 10.1097/BRS.0000000000003386.
2
Sacral chordoma: do the width of surgical margin and the use of photon/proton radiotherapy affect local disease control?骶骨脊索瘤:手术切缘的宽度和光子/质子放疗的应用是否会影响局部疾病控制?
Int Orthop. 2020 Feb;44(2):381-389. doi: 10.1007/s00264-019-04460-5. Epub 2019 Dec 20.
3
Long-term outcomes of high-dose single-fraction radiosurgery for chordomas of the spine and sacrum.脊柱和骶骨脊索瘤大剂量单次分割放射外科治疗的长期疗效
J Neurosurg Spine. 2019 Oct 18;32(1):79-88. doi: 10.3171/2019.7.SPINE19515. Print 2020 Jan 1.
4
Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.脊索瘤的新兴治疗靶点:基因组时代文献综述。
Neurosurgery. 2020 Feb 1;86(2):E118-E123. doi: 10.1093/neuros/nyz342.
5
Local and Distant Recurrence in Resected Sacral Chordomas: A Systematic Review and Pooled Cohort Analysis.骶骨脊索瘤切除术后的局部和远处复发:一项系统评价和汇总队列分析
Global Spine J. 2019 Apr;9(2):191-201. doi: 10.1177/2192568217741114. Epub 2018 May 30.
6
Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review.分子靶向治疗在脊索瘤治疗中的应用:一项系统综述
Front Oncol. 2019 Feb 1;9:30. doi: 10.3389/fonc.2019.00030. eCollection 2019.
7
Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.质子或碳离子治疗颅底脊索瘤的治疗结果:一项回顾性研究。
Radiat Oncol. 2018 Nov 26;13(1):232. doi: 10.1186/s13014-018-1173-0.
8
Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival.脊索瘤:流行病学和临床预后因素的系统回顾,预测无进展生存期和总生存期。
Eur Spine J. 2018 Dec;27(12):3043-3058. doi: 10.1007/s00586-018-5764-0. Epub 2018 Sep 15.
9
Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.骶骨脊索瘤的外科治疗:切缘阴性的整块切除是长期预后的决定因素。
Surg Technol Int. 2018 Nov 11;33:343-348.
10
Four-Level Vertebrectomy for En Bloc Resection of a Cervical Chordoma.四级椎体切除术用于整块切除颈椎脊索瘤。
World Neurosurg. 2018 Oct;118:316-323. doi: 10.1016/j.wneu.2018.07.153. Epub 2018 Jul 27.